Proud For Profits
  • Investing
  • Stock
  • Latest News
  • Economy
  • Investing
  • Stock
  • Latest News
  • Economy
No Result
View All Result
Proud For Profits
No Result
View All Result
Home Stock

Tesla, Spirit Airlines and CVS Health rise premarket; Nvidia falls

by
November 18, 2024
in Stock
0
Tesla, Spirit Airlines and CVS Health rise premarket; Nvidia falls

Investing.com — US stock futures traded in a mixed fashion Monday, with traders awaiting more corporate earnings as well as speeches from a number of Fed officials.

Here are some of the biggest premarket US stock movers today:

Tesla (NASDAQ:TSLA) stock surged 5.9% following reports from Bloomberg that the incoming Trump administration will establish a federal framework for fully self-driving vehicles and make it a top priority for the Department of Transportation.

Nvidia (NASDAQ:NVDA) stock fell 3.4% amid doubts over the strength of sales of its new Blackwell chips, ahead of the chipmaker’s quarterly earnings on Wednesday.

Spirit Airlines (NYSE:SAVE) stock rose 2.8% after the budget carrier filed for bankruptcy protection after years of mounting losses, stating that it has reached a prearranged deal with its bondholders to help it through the bankruptcy, which it expects to exit in the first quarter of next year.

Ford (NYSE:F) stock rose 0.3% despite the US auto safety regulator stating it had initiated a recall query into about 112,567 of the auto giant’s SUVs over an issue with seat belt retractors.

CVS Health (NYSE:CVS) stock rose 1.9% after the pharmacy chain said it would add four new members to its board in an agreement with Glenview Capital Management, including the hedge fund’s chief executive Larry Robbins.

Super Micro Computer (NASDAQ:SMCI) stock rose over 10% as investors awaited a planned filing that would allow the server maker to avoid being delisted

Astera Labs (NASDAQ:ALAB) stock rose 3% after Citi initiated coverage of the semiconductor stock with a ‘buy’ rating, saying the shares provide artificial intelligence investors with a unique opportunity.

Syndax Pharmaceuticals (NASDAQ:SNDX) stock rose 6% after the FDA approved its Revuforj drug for the treatment of certain leukemia patients.

This post appeared first on investing.com
Previous Post

Spirit Airlines files for bankruptcy, plans major debt restructuring

Next Post

Earnings call: Acme Corp reports mixed Q1 results, shares details on performance

Next Post
Earnings call: Acme Corp reports mixed Q1 results, shares details on performance

Earnings call: Acme Corp reports mixed Q1 results, shares details on performance

Enter Your Information Below To Receive Trading Ideas and Latest News

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Popular News

    NevGold Mobilizes Drill To Test Historical Leach Pads To Advance The Near-Term Antimony Production Scenario at Limo Butte

    NevGold Mobilizes Drill To Test Historical Leach Pads To Advance The Near-Term Antimony Production Scenario at Limo Butte

    March 13, 2026
    Cartier Cuts 7.1 g/t Au over 8.0 m at Portal ; New Shallow High-Grade Gold Zone Discovered

    Cartier Cuts 7.1 g/t Au over 8.0 m at Portal ; New Shallow High-Grade Gold Zone Discovered

    March 13, 2026
    US destroys 16 Iranian mine boats as Strait of Hormuz oil showdown escalates

    US destroys 16 Iranian mine boats as Strait of Hormuz oil showdown escalates

    March 12, 2026
    Track all markets on TradingView

    About Proud For Profits

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Main Categories

    • Investing
    • Stock
    • Latest News
    • Economy

    Latest News

    • NevGold Mobilizes Drill To Test Historical Leach Pads To Advance The Near-Term Antimony Production Scenario at Limo Butte
    • Cartier Cuts 7.1 g/t Au over 8.0 m at Portal ; New Shallow High-Grade Gold Zone Discovered
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2026 proudforprofits.com | All Rights Reserved

    No Result
    View All Result
    • Investing
    • Stock
    • Latest News
    • Economy

    Copyright © 2026 proudforprofits.com | All Rights Reserved